To clarify the related mechanisms of astrocytic GluN2A which protect neurons against the early Aβ synaptotoxicity through regulating NGF could provide a pharmacological strategies aiming to increase an endogenous neuroprotective NGF level for early treatment of AD. Here, NGF is linked to Alzheimer disease.